| A recommended scale for cognitive screening in clinical trials of Parkinson's disease KL Chou, MM Amick, J Brandt, R Camicioli, K Frei, D Gitelman, J Goldman, ... Movement Disorders 25 (15), 2501-2507, 2010 | 235 | 2010 |
| Solvent exposures and Parkinson disease risk in twins SM Goldman, PJ Quinlan, GW Ross, C Marras, C Meng, GS Bhudhikanok, ... Annals of neurology 71 (6), 776-784, 2012 | 209 | 2012 |
| Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation—critique and recommendations by movement disorders task force on rating scales for … ML Evatt, KR Chaudhuri, KL Chou, E Cubo, V Hinson, K Kompoliti, ... Movement disorders: official journal of the Movement Disorder Society 24 (5 …, 2009 | 202 | 2009 |
| Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort EY Uc, MP McDermott, KS Marder, SW Anderson, I Litvan, PG Como, ... Neurology 73 (18), 1469-1477, 2009 | 199 | 2009 |
| [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease A Siderowf, A Newberg, KL Chou, M Lloyd, A Colcher, HI Hurtig, MB Stern, ... Neurology 64 (10), 1716-1720, 2005 | 189 | 2005 |
| Measuring mild cognitive impairment in patients with Parkinson's disease C Marras, MJ Armstrong, CA Meaney, S Fox, B Rothberg, W Reginold, ... Movement Disorders 28 (5), 626-633, 2013 | 184 | 2013 |
| Sialorrhea in Parkinson's disease: a review KL Chou, M Evatt, V Hinson, K Kompoliti Movement Disorders 22 (16), 2306-2313, 2007 | 179 | 2007 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 176 | 2015 |
| Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment KL Chou, SL Galetta, GT Liu, NJ Volpe, JL Bennett, AK Asbury, LJ Balcer Journal of the neurological sciences 219 (1-2), 35-39, 2004 | 162 | 2004 |
| The spectrum of “off” in Parkinson's disease: what have we learned over 40 years? KL Chou, M Stacy, T Simuni, J Miyasaki, WH Oertel, K Sethi, ... Parkinsonism & Related Disorders 51, 9-16, 2018 | 161 | 2018 |
| A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease A McGarry, M McDermott, K Kieburtz, EA de Blieck, F Beal, K Marder, ... Neurology 88 (2), 152-159, 2017 | 138 | 2017 |
| Management of the hospitalized patient with Parkinson’s disease: current state of the field and need for guidelines MJ Aminoff, CW Christine, JH Friedman, KL Chou, KE Lyons, R Pahwa, ... Parkinsonism & related disorders 17 (3), 139-145, 2011 | 138 | 2011 |
| Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor KL Chou, HI Hurtig, JL Jaggi, GH Baltuch Movement disorders 20 (3), 377-380, 2005 | 138 | 2005 |
| Antipsychotic-induced extrapyramidal symptoms and their management P Dayalu, KL Chou Expert opinion on pharmacotherapy 9 (9), 1451-1462, 2008 | 127 | 2008 |
| Parkinson's disease‐related fatigue: a case definition and recommendations for clinical research BM Kluger, K Herlofson, KL Chou, JS Lou, CG Goetz, AE Lang, ... Movement Disorders 31 (5), 625-631, 2016 | 115 | 2016 |
| Fall frequency and risk assessment in early Parkinson's disease TS Voss, JJ Elm, CL Wielinski, MJ Aminoff, D Bandyopadhyay, KL Chou, ... Parkinsonism & related disorders 18 (7), 837-841, 2012 | 115 | 2012 |
| Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments KL Chou, S Messing, D Oakes, PD Feldman, A Breier, JH Friedman Clinical neuropharmacology 28 (5), 215-219, 2005 | 113 | 2005 |
| Sleep and fatigue in Parkinson's disease JH Friedman, KL Chou Parkinsonism & related disorders 10, S27-S35, 2004 | 110 | 2004 |
| Hospitalization in Parkinson disease: a survey of national Parkinson foundation centers KL Chou, J Zamudio, P Schmidt, CC Price, SA Parashos, BR Bloem, ... Parkinsonism & related disorders 17 (6), 440-445, 2011 | 109 | 2011 |
| Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates KL Chou, A Lenhart, RA Koeppe, NI Bohnen Parkinsonism & related disorders 20 (10), 1076-1080, 2014 | 105 | 2014 |
